EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Innovative nanodelivery systems for targeted breast cancer therapy: overcoming drug delivery challenges and exploring future perspectives

Dandan Su, Xiaolin Lai, Zhizhe Lin, Youfa Xu, Zhiqin Fu, Jianming Chen iD, Xin Wu iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04039-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Dandan Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: High-level Talents of Fujian University of Chinese Medicine, Shanghai Enterprise Technology Center, Shanghai Oriental Talent Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer chemotherapy is often limited by insufficient drug targeting, which can cause severe adverse effects on healthy tissues. The advent of nanodelivery systems offers a potential solution to this issue. It intricately enhances drug accumulation in tumor regions, while optimizing drug solubility, ensuring colloidal stability, and promoting cellular uptake, significantly improving the precision and efficacy of treatment, opening a gentler yet more effective new path for cancer therapy. This article begins with the pathogenesis of breast cancer and extends to the current treatment methods and their shortcomings, exploring in-depth the targeting therapeutic effects of five innovative nanodelivery technologies used in the treatment of breast cancer in recent years. Finally, it discusses the potential opportunities and challenges that nanodelivery systems may face in future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic AgentsDrug Delivery SystemsNanoparticlesNanoparticle Drug Delivery SystemHumansFemaleAnimals

Stichwörter der Autor:innen

Breast cancerDrug deliveryNanomaterialsNanomedicineTumor targeting

Substanzen

Antineoplastic AgentsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, China.
  • Shanghai Wei Er Lab, Shanghai, 201707, China.
  • Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, China. chenjm0711@163.com.
  • Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, China. wuxin007@126.com.
  • Shanghai Wei Er Lab, Shanghai, 201707, China. wuxin007@126.com.

ORCID-Profile: Jianming Chen, Xin Wu

Förderung

  • High-level Talents of Fujian University of Chinese Medicine
  • Shanghai Enterprise Technology Center
  • Shanghai Oriental Talent Youth Project

Zitieren

APA

Su, D., Lai, X., Lin, Z., Xu, Y., Fu, Z., Chen, J., & Wu, X. (2025). Innovative nanodelivery systems for targeted breast cancer therapy: overcoming drug delivery challenges and exploring future perspectives. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04039-5

Vancouver

Su D, Lai X, Lin Z, Xu Y, Fu Z, Chen J, et al. Innovative nanodelivery systems for targeted breast cancer therapy: overcoming drug delivery challenges and exploring future perspectives. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04039-5

BibTeX
@article{Su2025,
  author = {Su, Dandan and Lai, Xiaolin and Lin, Zhizhe and Xu, Youfa and Fu, Zhiqin and Chen, Jianming and Wu, Xin},
  title = {Innovative nanodelivery systems for targeted breast cancer therapy: overcoming drug delivery challenges and exploring future perspectives},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04039-5}
}
Kostenlos starten →